2021-2022 PDMP Annual Report

Prescription Drug Monitoring Program Annual Report | 2021-22 13 Technical Notes The current report year (RY22) covers the period from July 1, 2021 (Q3-Q4 2021) to June 30, 2022 (Q1-Q2 2022). Direct year-to-year comparisons are based on report years. After July 1, 2018, controlled substances include substances named or described in schedules II through V of section 893.03 Florida Statutes. Data was downloaded from PMP Advanced Analytics TM between June 30, 2022, to September 14, 2022, and summarizes the characteristics and prescribing patterns of the controlled substances reported to the PDMS. In this report, "patient" refers to Florida residents 18 years of age and older unless specified otherwise. Performance measures are consistently measured during each performance period to rule out any system-level changes that may lead to fluctuations in the data. For example, prior years' annual reports have noted system-level changes likely to impact data interpretation (e.g., incorporation of data from the United States (U.S.) Department of Veterans Affairs, tramadol reporting, hydrocodone rescheduling, and mandatory consultation). This report's population estimates are Annual Estimates of the Resident Population for Selected Age Groups by Sex for Florida: April 1, 2010, to July 1, 2019; April 1, 2020; and July 1, 2021 (Source: U.S. Census Bureau Population Division. Release Date: June 2021. Updated July 2022 with April 1, 2020, estimate).